Beijing Strong BiotechnologiesInc Balance Sheet Health
Financial Health criteria checks 5/6
Beijing Strong BiotechnologiesInc has a total shareholder equity of CN¥3.8B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 30.3%. Its total assets and total liabilities are CN¥5.3B and CN¥1.4B respectively. Beijing Strong BiotechnologiesInc's EBIT is CN¥633.1M making its interest coverage ratio 29.6. It has cash and short-term investments of CN¥1.0B.
Key information
30.3%
Debt to equity ratio
CN¥1.16b
Debt
Interest coverage ratio | 29.6x |
Cash | CN¥1.03b |
Equity | CN¥3.84b |
Total liabilities | CN¥1.44b |
Total assets | CN¥5.28b |
Recent financial health updates
Recent updates
Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?
Jul 25Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price
Jul 03An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued
Jun 14Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?
Mar 21Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified
Mar 03Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)
Feb 27Financial Position Analysis
Short Term Liabilities: 300406's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥247.6M).
Long Term Liabilities: 300406's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥1.2B).
Debt to Equity History and Analysis
Debt Level: 300406's net debt to equity ratio (3.4%) is considered satisfactory.
Reducing Debt: 300406's debt to equity ratio has increased from 0% to 30.3% over the past 5 years.
Debt Coverage: 300406's debt is well covered by operating cash flow (50.6%).
Interest Coverage: 300406's interest payments on its debt are well covered by EBIT (29.6x coverage).